Summit Therapeutics Inc [SMMT] Investment Guide: What You Need to Know

In a filing, Summit Therapeutics Inc revealed its Chief Financial Officer Dhingra Ankur acquired Company’s shares for reported $44254.0 on Dec 13 ’23. In the deal valued at $2.17 per share,20,400 shares were bought. As a result of this transaction, Dhingra Ankur now holds 254,958 shares worth roughly $0.84 million. Then, Zanganeh Mahkam bought 5,000 […]

Summit Therapeutics Inc [SMMT] Shares Jump Approximately 115.15% Over the Year

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Summit Therapeutics Inc shares valued at $44,254 were purchased by Dhingra Ankur on Dec 13 ’23. At $2.17 per share, Dhingra Ankur acquired 20,400 shares. The insider’s holdings grew to 254,958 shares worth approximately $0.91 million following […]

Investing in Summit Therapeutics Inc (SMMT) Is Getting More Attractive

Summit Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Dhingra Ankur acquired Company’s shares for reported $44254.0 on Dec 13 ’23. In the deal valued at $2.17 per share,20,400 shares were bought. As a result of this transaction, Dhingra Ankur now holds 254,958 shares worth roughly $1.05 million. Then, Zanganeh Mahkam bought 5,000 […]

The Attractiveness of Investing In Summit Therapeutics Inc (SMMT) is Growing

Summit Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Dhingra Ankur acquired Company’s shares for reported $44254.0 on Dec 13 ’23. In the deal valued at $2.17 per share,20,400 shares were bought. As a result of this transaction, Dhingra Ankur now holds 254,958 shares worth roughly $1.1 million. Then, Zanganeh Mahkam bought 5,000 […]

Short interest on SMMT sees a significant increase on Feb 15, 2024

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Summit Therapeutics Inc shares valued at $44,254 were purchased by Dhingra Ankur on Dec 13 ’23. At $2.17 per share, Dhingra Ankur acquired 20,400 shares. The insider’s holdings grew to 254,958 shares worth approximately […]

A Guide To The Risks Of Investing In Summit Therapeutics Inc (SMMT)

Summit Therapeutics Inc’s recently made public that its Chief Financial Officer Dhingra Ankur acquired Company’s shares for reported $44254.0 on Dec 13. In the deal valued at $2.17 per share,20,400 shares were bought. As a result of this transaction, Dhingra Ankur now holds 254,958 shares worth roughly $1.14 million. Then, Zanganeh Mahkam bought 5,000 shares, […]

Rise in SMMT’s short interest indicates Bearish sentiment

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Summit Therapeutics Inc shares valued at $44,254 were purchased by Dhingra Ankur on Dec 13. At $2.17 per share, Dhingra Ankur acquired 20,400 shares. The insider’s holdings grew to 254,958 shares worth approximately $1.16 […]

Summit Therapeutics Inc [SMMT] Investment Appeal on the Rise

In a filing, Summit Therapeutics Inc revealed its Chief Financial Officer Dhingra Ankur acquired Company’s shares for reported $44254.0 on Dec 13. In the deal valued at $2.17 per share,20,400 shares were bought. As a result of this transaction, Dhingra Ankur now holds 254,958 shares worth roughly $1.14 million. Then, Zanganeh Mahkam bought 5,000 shares, […]